Skip to contentEingeschlossene Patienten: 22.457 (Stand 01. November 2023) | |
---|
Amgevita® (Adalimumab) | 202 |
Benepali® (Etanercept) | 1141 |
Cimzia® (Certolizumab) | 1019 |
Enbrel® (Etanercept) | 2872 |
Erelzi® (Etanercept) | 491 |
Flixabi® (Infliximab) | 10 |
Hulio® (Adalimumab) | 221 |
Humira® (Adalimumab) | 2908 |
Hyrimoz® (Adalimumab) | 193 |
Idacio® (Adalimumab) | 59 |
Imraldi® (Adalimumab) | 192 |
Inflectra™ (Infliximab) | 16 |
Jyseleca® (Filgotinib) | 118 |
Kevzara® (Sarilumab) | 207 |
Kineret® (Anakinra) | 89 |
MabThera® (Rituximab) | 1459 |
Nepexto® (Etanercept) | 57 |
Olumiant® (Baricitinib) | 527 |
Orencia® (Abatacept) | 967 |
Remicade® (Infliximab) | 762 |
Remsima® (Infliximab) | 19 |
Rinvoq® (Upadacitinib) | 289 |
Rixathon® (Rituximab) | 20 |
RoActemra® (Tocilizumab) | 1371 |
Ruxience® (Rituximab) | 1 |
Simponi® (Golimumab) | 466 |
Xeljanz® (Tofacitinib) | 394 |
Yuflyma® (Adalimumab) | 15 |
Zessly® (Infliximab) | 2 |
Kontrollen | 6370 |